PureTech Health plc (PRTC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PRTC Revenue Growth
PRTC Revenue Analysis (2014–2025)
As of May 8, 2026, PureTech Health plc (PRTC) generated trailing twelve-month (TTM) revenue of $9.0 million, reflecting significant decline in growth of -30.5% year-over-year. The most recent quarter (Q4 2025) recorded $2.8 million in revenue, up 51.1% sequentially.
Looking at the longer-term picture, PRTC's 5-year compound annual growth rate (CAGR) stands at -11.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $16.4 million in 2018.
When compared to Healthcare sector peers including ROIV (-56.4% YoY), ATAI (+811.8% YoY), and RXRX (+11.0% YoY), PRTC has underperformed the peer group in terms of revenue growth. Compare PRTC vs ROIV →
PRTC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PRTCCurrent | $9M | -30.5% | -11.0% | -2114.7% | |
 ROIV | $29M | -56.4% | -15.6% | -3453.3% | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 RXRX | $75M | +11.0% | +85.4% | -867.9% | |
 ABSI | $3M | -66.3% | -10.1% | -4454.2% |
PRTC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.7M | -3.5% | $4.7M | 100.0% | $-98,525,000 | -2114.7% |
| 2024 | $4.8M | +45.0% | $1.3M | 26.0% | $-136,095,000 | -2818.9% |
| 2023 | $3.3M | +59.3% | $-1,603,000 | -48.1% | $-146,199,000 | -4390.4% |
| 2022 | $2.1M | -79.1% | $-136,815,000 | -6546.2% | $-197,807,000 | -9464.4% |
| 2021 | $10.0M | +19.6% | $-100,492,000 | -1007.0% | $-150,282,000 | -1506.0% |
| 2020 | $8.3M | -4.0% | $8.3M | 100.0% | $-119,531,000 | -1433.1% |
| 2019 | $8.7M | -46.9% | $-77,160,000 | -888.1% | $-135,399,000 | -1558.5% |
| 2018 | $16.4M | +2418.6% | $-61,031,000 | -372.8% | $-104,019,000 | -635.4% |
| 2017 | $650K | -85.3% | $-70,385,000 | -10828.5% | $-115,420,000 | -17756.9% |
| 2016 | $4.4M | -62.3% | $2.9M | 64.6% | $-73,929,000 | -1668.4% |
See PRTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRTC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRTC — Frequently Asked Questions
Quick answers to the most common questions about buying PRTC stock.
Is PRTC's revenue growth accelerating or slowing?
PRTC revenue declined -30.5% year-over-year, contrasting with the 5-year CAGR of -11.0%. TTM revenue fell to $9M. This reverses the prior growth trend.
What is PRTC's long-term revenue growth rate?
PureTech Health plc's 5-year revenue CAGR of -11.0% reflects the variable expansion pattern. Current YoY growth of -30.5% is below this long-term average.
How is PRTC's revenue distributed by segment?
PRTC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.